Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
I. A. Harsch, E. G. Hahn, S. Pour Schahin (Erlangen, Bavaria, Germany). Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years. Eur Respir J 2007; 30: Suppl. 51, 2776

Member's Comments

No comment yet.

Related content which might interest you: The influence of continuous positive airway pressure (CPAP) on response to incremental exercise in sleep apnea patients Source: Eur Respir J 2004; 24: Suppl. 48, 567s Year: 2004 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Standard continuous positive airway pressure (CPAP) Source: Annual Congress 2007 - Practical workshop: continuous positive airway pressure (CPAP) Year: 2007 3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010 Improvement of machine compliance when switching patients with OSA to C-flex Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005 Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1c) even in euglycemic obstructive sleep apnoea patients within normal HbA1c range Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Does continuous positive airway pressure (CPAP) improve the exercise capacity of adults with tracheomalacia? Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006 A new UK approach in the management of patients on continuous positive airway pressure (CPAP) therapy Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003 The experience of autotitration of continuous positive airway pressure (CPAP) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 568s Year: 2004 Pressure reduction during exhalation in sleep apnea patients treated by continuous positive airway pressure (CPAP) Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment Source: Eur Respir J 2006; 27: 756-760 Year: 2006 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010